These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 25453365)
1. Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle. Wurdinger T; Deumelandt K; van der Vliet HJ; Wesseling P; de Gruijl TD Biochim Biophys Acta; 2014 Dec; 1846(2):560-75. PubMed ID: 25453365 [TBL] [Abstract][Full Text] [Related]
2. Immune microenvironment of gliomas. Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634 [TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy. Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117 [TBL] [Abstract][Full Text] [Related]
4. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma. Roesch S; Rapp C; Dettling S; Herold-Mende C Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898 [TBL] [Abstract][Full Text] [Related]
5. Functional assay to assess T-cell inhibitory properties of myeloid derived suppressor cells (MDSCs) isolated from the tumor microenvironment of murine glioma models. Alghamri MS; Kamran N; Kadiyala P; Lowenstein PR; Castro MG Methods Enzymol; 2020; 632():215-228. PubMed ID: 32000897 [TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions. Liu J; Piranlioglu R; Ye F; Shu K; Lei T; Nakashima H Front Cell Infect Microbiol; 2023; 13():1141034. PubMed ID: 37234776 [TBL] [Abstract][Full Text] [Related]
7. Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy. Kamran N; Chandran M; Lowenstein PR; Castro MG Clin Immunol; 2018 Apr; 189():34-42. PubMed ID: 27777083 [TBL] [Abstract][Full Text] [Related]
8. Role of myeloid cells in the immunosuppressive microenvironment in gliomas. Locarno CV; Simonelli M; Carenza C; Capucetti A; Stanzani E; Lorenzi E; Persico P; Della Bella S; Passoni L; Mavilio D; Bonecchi R; Locati M; Savino B Immunobiology; 2020 Jan; 225(1):151853. PubMed ID: 31703822 [TBL] [Abstract][Full Text] [Related]
9. Role of Infiltrating Microglia/Macrophages in Glioma. Catalano M; D'Alessandro G; Trettel F; Limatola C Adv Exp Med Biol; 2020; 1202():281-298. PubMed ID: 32034719 [TBL] [Abstract][Full Text] [Related]
10. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. Lin H; Liu C; Hu A; Zhang D; Yang H; Mao Y J Hematol Oncol; 2024 May; 17(1):31. PubMed ID: 38720342 [TBL] [Abstract][Full Text] [Related]
11. New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs. Lakshmanachetty S; Cruz-Cruz J; Hoffmeyer E; Cole AP; Mitra SS Cells; 2021 Apr; 10(4):. PubMed ID: 33919732 [TBL] [Abstract][Full Text] [Related]
12. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells. Hasan MN; Luo L; Ding D; Song S; Bhuiyan MIH; Liu R; Foley LM; Guan X; Kohanbash G; Hitchens TK; Castro MG; Zhang Z; Sun D Theranostics; 2021; 11(3):1295-1309. PubMed ID: 33391535 [No Abstract] [Full Text] [Related]
13. Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model. Chae M; Peterson TE; Balgeman A; Chen S; Zhang L; Renner DN; Johnson AJ; Parney IF Neuro Oncol; 2015 Jul; 17(7):978-91. PubMed ID: 25537019 [TBL] [Abstract][Full Text] [Related]
14. Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy. Lin C; Wang N; Xu C Front Immunol; 2023; 14():1123853. PubMed ID: 36969167 [TBL] [Abstract][Full Text] [Related]
15. ALOX5 contributes to glioma progression by promoting 5-HETE-mediated immunosuppressive M2 polarization and PD-L1 expression of glioma-associated microglia/macrophages. Chen T; Liu J; Wang C; Wang Z; Zhou J; Lin J; Mao J; Pan T; Wang J; Xu H; He X; Wu D; Liu Z J Immunother Cancer; 2024 Aug; 12(8):. PubMed ID: 39142719 [TBL] [Abstract][Full Text] [Related]
16. Tumor-derived extracellular vesicles: how they mediate glioma immunosuppression. Ma T; Su G; Wu Q; Shen M; Feng X; Zhang Z Mol Biol Rep; 2024 Jan; 51(1):235. PubMed ID: 38282090 [TBL] [Abstract][Full Text] [Related]
17. Microglia-glioma cross-talk: a two way approach to new strategies against glioma. Arcuri C; Fioretti B; Bianchi R; Mecca C; Tubaro C; Beccari T; Franciolini F; Giambanco I; Donato R Front Biosci (Landmark Ed); 2017 Jan; 22(2):268-309. PubMed ID: 27814616 [TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment. Mi Y; Guo N; Luan J; Cheng J; Hu Z; Jiang P; Jin W; Gao X Front Immunol; 2020; 11():737. PubMed ID: 32391020 [TBL] [Abstract][Full Text] [Related]
19. TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma. Zinnhardt B; Müther M; Roll W; Backhaus P; Jeibmann A; Foray C; Barca C; Döring C; Tavitian B; Dollé F; Weckesser M; Winkeler A; Hermann S; Wagner S; Wiendl H; Stummer W; Jacobs AH; Schäfers M; Grauer OM Neuro Oncol; 2020 Jul; 22(7):1030-1043. PubMed ID: 32047908 [TBL] [Abstract][Full Text] [Related]
20. Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy. Wang C; Chen Q; Chen M; Guo S; Hou P; Zou Y; Wang J; He B; Zhang Q; Chen L; Luo L Cancer Immunol Immunother; 2023 Jun; 72(6):1685-1698. PubMed ID: 36624155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]